Related Experiment Videos
Isoproterenol infusion--an alternative to exercise testing.
Indian Heart Journal
|March 1, 1989
Summary
Isoproterenol infusion effectively simulates exercise stress, identifying coronary artery disease (CAD) with diagnostic ST segment depression below 130 BPM. This method is a safer alternative to traditional exercise testing for evaluating cardiac patients.
Area of Science:
- Cardiology
- Pharmacology
- Exercise Physiology
Background:
- Exercise stress testing is a common method for diagnosing coronary artery disease (CAD).
- Isoproterenol is a sympathomimetic agent that can increase heart rate and myocardial contractility, simulating exercise.
- Evaluating the safety and efficacy of isoproterenol as an alternative to exercise testing is crucial.
Purpose of the Study:
- To assess the utility of isoproterenol infusion as an exercise-simulating agent in individuals with and without Coronary Artery Disease (CAD).
- To compare the diagnostic accuracy of isoproterenol infusion with traditional exercise testing.
Main Methods:
- Twenty subjects (10 normal, 10 with CAD) received intravenous isoproterenol infusions in 0.5 ug increments every 3 minutes.
- Computerized electrocardiogram (ECG) monitoring (Marquette Electronics--MAC PC) was used throughout the infusions.
- Heart rate and ST segment changes were analyzed to identify signs of ischemia.
Main Results:
- Normal volunteers showed no significant ST segment depression, even at heart rates of 130 BPM.
- Subjects with CAD exhibited diagnostic ischemic ST segment depression at heart rates below 130 BPM.
- No serious complications were reported in any participants during or after the isoproterenol infusion test.
Conclusions:
- Isoproterenol infusion effectively induces physiological changes similar to exercise, enabling the detection of significant coronary artery disease.
- The study suggests that isoproterenol infusion is a viable and potentially superior alternative to exercise stress testing for evaluating patients with suspected or known CAD.
- This pharmacological stress test demonstrated a favorable safety profile.